Category Archives: "Letter to Investors"

In our December 2020 Letter to Investors we take a look at what 2021 might have in store for investors as the vaccine rollout confronts new, more virulent forms of the virus.

In our November 2020 Letter to Investors we review what drove markets in an historic month for sector and style rotation and touch on how we have been positioning the Ophir Funds.

In our October 2020 Letter to Investors we review how we have been positioning our portfolios in light of the US election result and better than expected vaccine news.

In our September 2020 Letter to Investors we review how not overpaying for earnings growth in our Funds provides protection no matter which style of investing is in vogue.

In our August 2020 letter to investors we review how narrow the recent market rally has been as well as delve into a better than expected Australian reporting season, though note much uncertainty remains.

In our July 2020 letter to investors we review longer term performance and some key market themes that caught our eye, including a drop in volatility.

In our June Letter to Investors we reflect on what has been a year to remember for equity markets and assess whether they are over-valued. We also outline four factors we believe are key to the Ophir Funds outperforming during “bad” markets

In our May 2020 Letter to Investors we discuss whether the remarkable rise in global share markets can continue and why as investors now is the time to be very selective.

In our April 2020 Letter to Investors we review what caused markets to rebound, what we’ve been doing about it, and identify some trends emerging in consumer behaviour.

In our March 2020 Letter to Investors we review the historic nature of the month of March, the challenges and opportunities that lie ahead and how we are positioning the Funds.